Canadian patent law not a dramatic change, rules Eli Lilly tribunal
The NAFTA tribunal in Eli Lilly v Canada found that a recently developed "promise utility doctrine" in Canadian jurisprudence on pharmaceutical patents did not represent a dramatic change from previous Canadian law, the newly published award reveals.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10